Cocrystal Pharma, Inc. (COCP)
1.12
-0.01
(-0.88%)
USD |
NASDAQ |
May 29, 16:00
1.12
0.00 (0.00%)
After-Hours: 20:00
Cocrystal Pharma EPS Diluted (Quarterly) : -0.1668 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CNBX Pharmaceuticals, Inc. | 0.00 |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | -0.90 |
| Fulcrum Therapeutics, Inc. | -0.2479 |
| Definium Therapeutics, Inc. | -0.7087 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.299M |
| Revenue (Quarterly) | 0.225M |
| Total Expenses (Quarterly) | 2.524M |
| Enterprise Value | 12.10M |
| Gross Profit Margin (Quarterly) | 59.56% |
| Profit Margin (Quarterly) | -1.02K% |
| Earnings Yield | -65.29% |
| Normalized Earnings Yield | -65.29 |